Growth hormone (GH) administration for six months showed promising results in ameliorating NAFLD in overweight and obese individuals. Specifically, cT1 measurements revealed significant improvements in liver disease activity, suggesting the potential of GH therapy as a novel approach for managing NAFLD in this population.
Welcome to Perspectum Medical Education
You are entering a website that is scientific in nature and created for healthcare professionals.
Are you a healthcare professional?